Monoclonal antibodies anti-CD3, anti-TCR alpha beta and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon gamma.
Monoclonal antibodies anti-CD3, anti-TCR alpha beta and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon gamma. Cancer Immunol Immunother. 1992; 35(5):335-41.
-
Antibodies, Monoclonal
-
Antigens, CD
-
Antigens, Differentiation, T-Lymphocyte
-
CD2 Antigens
-
CD3 Complex
-
CD58 Antigens
-
Cell Adhesion Molecules
-
Cytotoxicity, Immunologic
-
Humans
-
Intercellular Adhesion Molecule-1
-
Interferon-gamma
-
Killer Cells, Lymphokine-Activated
-
Leukemia, Erythroblastic, Acute
-
Lymphocyte Function-Associated Antigen-1
-
Lymphocytes, Tumor-Infiltrating
-
Membrane Glycoproteins
-
Receptors, Antigen, T-Cell, alpha-beta
-
Receptors, IgG
-
Receptors, Immunologic